Login / Signup

"Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study": Author's reply.

Timothée KlopfensteinVincent GendrinSouheil Zayet
Published in: Journal of medical virology (2022)
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • ejection fraction
  • sars cov
  • newly diagnosed
  • prognostic factors
  • oxidative stress
  • patient reported